Mon, May 9, 2022

Andrew Fein Maintained (CCCC) at Strong Buy with Decreased Target to $35 on, May 9th, 2022

Andrew Fein of HC Wainwright & Co., Maintained "C4 Therapeutics, Inc." (CCCC) at Strong Buy with Decreased Target from $63 to $35 on, May 9th, 2022.

Andrew has made no other calls on CCCC in the last 4 months.



There are 4 other peers that have a rating on CCCC. Out of the 4 peers that are also analyzing CCCC, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Derek Archila of "Wells Fargo" Initiated at Hold and Held Target at $25 on, Thursday, February 10th, 2022


These are the ratings of the 3 analyists that currently disagree with Andrew


  • Colin Bristow of "UBS" Maintained at Strong Buy with Decreased Target to $26 on, Monday, April 18th, 2022
  • Etzer Darout of "BMO Capital" Maintained at Buy with Decreased Target to $20 on, Monday, April 11th, 2022
  • Eric Joseph of "JP Morgan" Initiated at Buy and Held Target at $43 on, Thursday, March 10th, 2022